JA
June Sherie Almenoff
Director

June Sherie Almenoff insider trades: Tenax Therapeutics (TENX) stock buys and sales

Director, Tenax Therapeutics Last trade Nov 18, 2025 46 Form 4 filings
$0
Sold, last 12 months
0 sales
$15K
Bought, last 12 months
1 buy
13
Open-market trades
since 2011
7
Companies
last trade 2025

Trades on the price chart

Daily close, with an arrow on each day they bought or sold

Companies

Where June reports to the SEC

and 1 more company

Open-market buys and sales

13 trades reported on SEC Form 4, newest first

DateStockTypeValue
Nov 18, 2025TENX↑ Buy$15K
Nov 13, 2024AVTX↑ Buy$13K
Jan 4, 2019BCLI↑ Buy$5K
Aug 27, 2018INNT↑ Buy$7K
Feb 6, 2015OHRP↑ Buy$41K
Sep 3, 2014OHRP↑ Buy$18K
Jun 26, 2014OHRP↑ Buy$27K
Apr 8, 2014OHRP↑ Buy$56K
Feb 4, 2014FURX↓ Sell$13.3M
Aug 15, 2012FURX↑ Buy$19K
May 17, 2012FURX↑ Buy$30K
Feb 24, 2012FURX↑ Buy$55K
Sep 9, 2011FURX↑ Buy$15K

Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.

Other TENX insiders

Open-market trades in the last 12 months

About June Sherie Almenoff's insider trades

June Sherie Almenoff is a director at Tenax Therapeutics (TENX). Since Sep 9, 2011, June has reported 12 open-market purchases worth $299K and 1 sale worth $13.3M on SEC Form 4. In the last 12 months: 1 buy ($15K).

Their filings also include grants and awards (30 filings), shares returned to the company (2 filings), option exercises (2 filings). These aren't open-market trades and aren't counted above.

How to read insider trades

Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every TENX insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.